Should there be an app for that?

Has drug pricing reform already stalled? And how far has tech come in medicine?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT's Lev Facher joins us to explain how the latest twist in Congress could imperil a bipartisan push to lower drug costs. Then, Baylor medical ethicist Stephanie Morain stops by to explain why a new crop of apps to match cancer patients with clinical trials comes with some serious concerns. Finally, STAT's Casey Ross dials in to talk about how the giants of tech are making inroads in health and medicine.

You can listen to the episode here. To listen to future episodes, be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.